The Burden of Cancer in Member Countries of the Association of Southeast Asian Nations (ASEAN)

  • Kimman, Merel (The George Institute for Global Health) ;
  • Norman, Rosana (The University of Queensland, Queensland Children's Medical Research Institute and School of Population Health) ;
  • Jan, Stephen (The George Institute for Global Health) ;
  • Kingston, David (University of New South Wales, School of Medical Sciences) ;
  • Woodward, Mark (The George Institute for Global Health)
  • Published : 2012.02.29


This paper presents the most recent data on cancer rates and the burden of cancer in the ASEAN region. Epidemiological data were sourced from GLOBOCAN 2008 and disability adjusted life years (DALYs) lost were estimated using the standard methodology developed within the World Health Organization's Global Burden of Disease study. Overall, it was estimated there were over 700,000 new cases of cancer and 500,000 cancer deaths in ASEAN in the year 2008, leading to approximately 7.5 million DALYs lost in one year. The most commonly diagnosed cancers were lung (98,143), breast (86,842) and liver cancers (74,777). The most common causes of cancer death were lung cancer (85,772), liver cancer (69,115) and colorectal cancer (44,280). The burden of cancer in terms of DALYs lost was highest in Laos, Viet Nam and Myanmar and lowest in Brunei, Singapore and the Philippines. Significant differences in the patterns of cancer from country to country were observed. Another key finding was the major impact played by population age distribution on cancer incidence and mortality. Cancer rates in ASEAN are expected to increase with ageing of populations and changes in lifestyles associated with economic development. Therefore, ASEAN member countries are strongly encouraged to put in place cancer-control health care policies, focussed on strengthening the health systems to cope with projected increases in cancer prevention, treatment and management needs.


  1. Ahmad OB, C Boschi-Pinto, AD Lopez, et al (2001). Age standardization of rates: a new WHO standard, World Health Organization.
  2. Begg S, T Vos, B Barker, et al (2007). The burden of disease and injury in Australia 2003 PHE 82, Canberra. AIHW.
  3. Boyle P, Levin B, and International Agency for Research on Cancer (2008). World Cancer Report. Lyon, WHO Press.
  4. Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 18, 1688-94.
  5. de Kok IM, Wong CS, Chia KS, et al (1966). Gender differences in the trend of colorectal cancer incidence in Singapore, 1968-2002. Int J Colorectal Dis, 23, 461-7.
  6. Ezzati M, Henley SJ, Lopez AD, Thun MJ (2005). Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. Int J Cancer, 116, 963-71.
  7. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
  8. Garland SM, Cuzick J, Domingo EJ, et al (2008). Recommendations for cervical cancer prevention in Asia Pacific. Vaccine, 12, M89-98.
  9. Hollinger FB, Liang TJ (2001). Hepatitis B Virus Fields Virology Philadelphia, Lippincott Williams & Wilkins: 2971-3036.
  10. Institute for Health Metrics and Evaluation (2011). The Challenge Ahead: Progress and setbacks in breast and cervical cancer. Seattle, WA, IHME, 2011.
  11. Jan S, Kimman M, Kingston D, Woodward M (2012). The Socioeconomic Burden of Cancer in member countries of the Association of Southeast Asian Nations (ASEAN) - Stakeholder Meeting Report Asian Pac J Cancer Prev, 13, 407-9.
  12. Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
  13. Kanavos P (2006). The rising burden of cancer in the developing world. Ann Oncol, 8, viii15-viii23.
  14. Kimman M, Jan S, Kingston D, et al (2012). The socioeconomic impact of cancer in member countries of the Association of Southeast Asian Nations (ASEAN): the ACTION study protocol. Asian Pac J Cancer Prev, 13, 421-5.
  15. Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R (2011). Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol, 23, 633-41.
  16. Lancet (2010). Moving cancer up the global health agenda. Lancet, 375, 2051.
  17. Mathers C, Boersma T, Ma Fat D (2008). The global burden of disease: 2004 update. Geneva, World Health Organization.
  18. Mathers CD, Vos T, Lopez AD, et al (2001). National Burden of Disease Studies: A Practical Guide. Global Program on Evidence for Health Policy. Geneva.
  19. Mathew A, George PS (2009). Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Asian Pac J Cancer Prev, 10, 645-50.
  20. Moore, MA, Attasara P, Khuhaprema T, et al (2010). Cancer epidemiology in mainland South-East Asia - past, present and future. Asian Pac J Cancer Prev, 11 Suppl 2, 67-80.
  21. Moore MA, Manan AA, Chow KY, et al (2010). Cancer epidemiology and control in peninsular and island South- East Asia - past, present and future. Asian Pac J Cancer Prev, 11 Suppl 2, 81-98.
  22. Murray CJ, Lopez AD (1997). Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 3491, 269-76.
  23. Parkin DM (2006). The global health burden of infectionassociated cancers in the year 2002. Int J Cancer, 118, 3030-44.
  24. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 83, 18-29.<18::AID-IJC5>3.0.CO;2-M
  25. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, World Population Prospects: The 2008 Revision,, May 02, 2011.
  26. Stouthard MEA, Essink-Bot M, Bonsel GJ, et al (1997). Disability weights for diseases in the Netherlands, Department of Public Health, Erasmus University Rotterdam, the Netherlands.
  27. Thun MJ, DeLancey JO, Center MM, et al (2010). The global burden of cancer: priorities for prevention. Carcinogenesis, 31, 100-10.
  28. United Nations Non-Governmental Liaison Service (2010). Towards a Global MDG Breakthrough Plan. Geneva.
  29. Valsecchi MG, Steliarova-Foucher E (2008). Cancer registration in developing countries: luxury or necessity? Lancet Oncol, 9, 159-67.
  30. World Health Organization (WHO) Databank. WHO statistical information system [Internet]. Geneva: WHO. http://www.
  31. Youlden DR, Cramb SM, Baade PD (2008). The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol, 3, 819-31.

Cited by

  1. MMP1 rs1799750 Single Nucleotide Polymorphism and Lung Cancer Risk: A Meta-analysis vol.13, pp.12, 2012,
  2. Cytotoxicity, Apoptosis Induction and Anti-Metastatic Potential of Oroxylum indicum in Human Breast Cancer Cells vol.13, pp.6, 2012,
  3. Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis vol.13, pp.6, 2012,
  4. Association Between TP53 Arg72Pro Polymorphism and Hepatocellular Carcinoma Risk: A Meta-analysis vol.13, pp.9, 2012,
  5. Caring for Women With Gynecologic Cancers Around the World vol.35, pp.6, 2012,
  6. Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection vol.109, pp.6, 2013,
  7. Time Trend of Out-of-pocket Expenditure among Cancer Inpatients: Evidence from Korean Tertiary Hospitals vol.14, pp.11, 2013,
  8. Four Genetic Polymorphisms of Lymphotoxin-Alpha Gene and Cancer Risk: A Systematic Review and Meta-Analysis vol.8, pp.12, 2013,
  9. A Single Measure of Cancer Burden Combining Incidence with Mortality Rates for Worldwide Application vol.15, pp.1, 2014,
  10. Calculation of Life-Time Death Probability due Malignant Tumors Based on a Sampling Survey Area in China vol.15, pp.10, 2014,
  11. Copayment Policy Effects on Healthcare Spending and Utilization by Korean Lung Cancer Patients at End of Life: A Retrospective Cohort Design 2003-2012 vol.15, pp.13, 2014,
  12. Cancers of the Young Population in Brunei Darussalam vol.15, pp.15, 2014,
  13. Fibroblast growth factor receptor 4 as a potential prognostic and therapeutic marker in colorectal cancer vol.19, pp.1, 2014,
  14. Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case–control studies vol.35, pp.3, 2014,
  15. A Prospective Study: Current Problems in Radiotherapy for Nasopharyngeal Carcinoma in Yogyakarta, Indonesia vol.9, pp.1, 2014,
  16. Current Status of Cancer Care for Young Patients with Nasopharyngeal Carcinoma in Jakarta, Indonesia vol.9, pp.7, 2014,
  17. Relationships between cancer pattern, country income and geographical region in Asia vol.15, pp.1, 2015,
  18. Effectiveness of Tobacco Education for Pharmacy Students in Indonesia vol.15, pp.24, 2015,
  19. Gynaecological Cancer Mortality in Serbia, 1991-2010: A Joinpoint Regression Analysis vol.16, pp.1, 2015,
  20. Characteristics of Liver Cancer at Khmer-Soviet Friendship Hospital in Phnom Penh, Cambodia vol.16, pp.1, 2015,
  21. Strobilanthes crispus Juice Concentrations and Anticancer Effects on DNA Damage, Apoptosis and Gene Expression in Hepatocellular Carcinoma Cells vol.16, pp.14, 2015,
  22. Burden of Cancers Related to Smoking among the Indonesian Population: Premature Mortality Costs and Years of Potential Life Lost vol.16, pp.16, 2015,
  23. Impact of Smoking Cessation Training for Community Pharmacists in Indonesia vol.16, pp.8, 2015,
  24. The relationship between economic characteristics and health-related quality of life in newly diagnosed cancer patients in Southeast Asia: results from an observational study vol.24, pp.4, 2015,
  25. Estimating the Burden of Cancers Attributable to Smoking Using Disability Adjusted Life Years in Indonesia vol.17, pp.3, 2016,
  26. Celecoxib, a COX-2 Selective Inhibitor, Induces Cell Cycle Arrest at the G2/M Phase in HeLa Cervical Cancer Cells vol.17, pp.4, 2016,
  27. Formulation and Cytotoxicity of Ribosome-Inactivating Protein Mirabilis Jalapa L. Nanoparticles Using Alginate-Low Viscosity Chitosan Conjugated with Anti-Epcam Antibodies in the T47D Breast Cancer Cell Line vol.17, pp.4, 2016,
  28. High prevalence of malnutrition and deranged relationship between energy demands and food intake in advanced non-small cell lung cancer vol.26, pp.4, 2016,
  29. Simulation and Visualization of Liver Cancer Ablation Focus in Optical Surgical Navigation vol.40, pp.1, 2016,
  30. Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries vol.15, pp.1, 2017,
  31. Study on expression of CDH4 in lung cancer vol.15, pp.1, 2017,
  32. management in ASEAN: The Bangkok consensus report vol.33, pp.1, 2017,
  33. The inhibition of Typhonium flagelliforme Lodd. Blume leaf extract on COX-2 expression of WiDr colon cancer cells vol.6, pp.3, 2016,
  34. Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells vol.51, pp.5, 2017,
  35. Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries pp.37, 2017,
  36. Training Future Leaders: Experience from China-ASEAN Cancer Control Training Program pp.1543-0154, 2018,